Cover story: 2021 saw many initiatives taken by the APAC region to strengthen their capacities for effective preparedness and for the prevention of new and existing infectious diseases.
Date : 27 Dec, 2021
Biospectrum, December 2021: Launched India’s first high sensitivity Hep C kit
Transasia further strengthened its COVID-19 testing portfolio by launching ErbaMDx COVID-19 RT-PCR kit with five times greater sensitivity to detect even low viral load. Besides this, we recently introduced ErbaLisa HCV Gen 4 Ag+Ab, India’s first and only indigenously developed 4th generation ELISA assay for detection of Hepatitis C virus. It is intended for early detection of Hepatitis C infection. We also introduced the ErbaQik rapid test kit for four critical infections namely HIV, HbsAg, HCV and Syphilis. These kits provide results in 20 minutes and have been approved by National Institute of Biologicals (NOB), Pune